QA: Arvinas INC in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001655759_2026_Arvinas_INC.pdf

Logs

Graph

Absolute values for 0001655759, Arvinas INC

  xvar xval
0 AssetsCurrent 700,700,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 5,200,000
3 remainder_Assets 12,000,000
4 LiabilitiesCurrent 142,500,000
5 LiabilitiesNoncurrent 141,500,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 111,812,824
9 ResearchAndDevelopmentExpense 158,840,102
10 remainder_Expenses 401,810
11 remainder_Revenues 262,776,078
12 remainder_NetIncome 39,730,625
13 remainder_ComprehensiveNetIncome 1,456,957
  yvar yval
0 Assets 717,900,000
1 Liabilities 284,000,000
2 Expenses 271,054,736
3 Revenues 262,776,078
4 StockholdersEquity 433,900,000
5 NetIncome 31,451,967
6 ComprehensiveNetIncome 32,180,446
7 BaseVar 788,459,198
8 EconomicCapitalRatiobeforeLimitedLiability 1.95
9 EconomicCapitalRatio 2.99

Edgar->Model Mapping

Feature Distribution

Change over Time